Business · 16/10/2025Updated: 10/17/2026 · 1 min read
FDA Announces Dual Labeling Guidance for New Animal Drugs
The FDA has released a final guidance for industry on dual labeling of new animal drugs for treating New World screwworm myiasis, allowing for both fully approved and conditionally approved uses.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →